Streetbeat News

Products Services

OTLK

Outlook Therapeutics' stock price increased following the announcement that the European Union CHMP has given a positive opinion on ONS-5010 for treating Wet AMD.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:20 pm

MTNB

Matinas BioPharma reported a complete clinical response in three patients with serious invasive Fusarium infection after treatment with MAT2203, indicating positive outcomes from its drug trial.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:16 pm

BTCUSD

ETHUSD

LULU

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin show mixed performance amid a decrease in weekly jobless claims. Ripple's CEO comments on SEC's actions against Ethereum and XRP. Lululemon's weak outlook impacts pre-market session alongside Nike. US political tensions rise with Marjorie Taylor Greene's statements. Taiwan's tech surge and China's investigation into PwC over Evergrande fraud affect the global economy. Apple faces an antitrust lawsuit, while Tesla's Cybertruck production ramps up. Air travel costs are expected to rise due to airlines passing on decarbonization expenses. Various companies face legal and market challenges.

Portfolio Pulse from Akanksha Bakshi

March 22, 2024 | 1:13 pm

BIDU

Baidu's stock price increased after a report by the Wall Street Journal indicated that Apple had discussions with Baidu regarding the use of AI technology in Apple's devices.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:06 pm

ADSE

ADS-TEC Energy showcased its ChargeBox, a battery-buffered, ultra-fast charging platform, at the EV Charging Summit & Expo. The ChargeBox supports CCS1 and will soon support NACS charging plugs, enabling ultra-fast charging on power-limited grids. This innovation aims to make ultra-fast charging as common as air conditioning in large buildings. CEO Thomas Speidel also discussed how their business models will reduce charging costs.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:04 pm

EJH

E-Home Household Services Holdings has announced the launch of an AI Intelligent Domestic Customer Service platform. This new service aims to enhance customer experience by leveraging artificial intelligence to improve service efficiency and response times.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:03 pm

AAPL

Apple Inc. is facing a new antitrust lawsuit from the U.S. Department of Justice, which could potentially increase consumer demand for alternative smartphones. Entrepreneur Vivek Ramaswamy discussed the lawsuit's implications, suggesting it could open opportunities for new entrants in the smartphone market. The lawsuit accuses Apple of restricting competitors' access to iPhone hardware and software, marking the third antitrust case against the company in 14 years. Apple has vowed to fight the lawsuit, stating it threatens its innovation capabilities.

Portfolio Pulse from Ananya Gairola

March 22, 2024 | 12:34 pm

FDX

LULU

OTLK

FedEx (FDX) shares rose by 13% after beating Q3 EPS expectations and announcing a new $5 billion share repurchase program. Lululemon Athletica (LULU) shares fell by 14% due to Q1 guidance below estimates. Outlook Therapeutics (OTLK) surged 61% after receiving a positive CHMP opinion in the EU for ONS-5010, a treatment for Wet AMD.

Portfolio Pulse from ryanfaloona@benzinga.com

March 22, 2024 | 12:33 pm

BLIN

Bridgeline Digital, Inc. (NASDAQ:BLIN), a marketing technology company, announced its AI-driven search platform, HawkSearch, has been selected by an automotive accessories manufacturer to enhance the eCommerce experience on its sites. HawkSearch will improve product discovery in the manufacturer's catalog of over 7,000 SKUs with features like autocomplete, dropdown selections, and faceted search capabilities. Additionally, HawkSearch Recommendations will offer personalized shopping experiences, aiming to increase site conversions by suggesting items based on user behavior.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 12:33 pm

TELO

Telomir Pharmaceuticals announced the release of pre-clinical data for its lead development product, Telomir-1, which will be presented at the Global Longevity Federation Conference in Las Vegas on March 26th. The data shows that Telomir-1 can elongate telomere caps on human normal embryonic fibroblast cells, addressing telomere shortening, a major contributor to aging as reported by The New York Times.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 12:32 pm